Atherosclerosis

• 

  Subject Areas on Research

  • 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). 
  • A Cluster Analysis of the Japanese Multicenter Outpatient Registry of Patients With Atrial Fibrillation. 
  • A combined clinical and biomarker approach to predict diuretic response in acute heart failure. 
  • A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus to coronary atherosclerosis via interactions between genetic variants and residential exposure to traffic. 
  • A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus. 
  • A role of matrix metalloproteinase-8 in atherosclerosis. 
  • A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use. 
  • ACP Journal Club. ACC/AHA Pooled Cohort Risk Equations predicted 5-y risk for CV events in adults considered for statin initiation. 
  • ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. 
  • ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. 
  • Acoustic radiation force impulse imaging for noninvasive characterization of carotid artery atherosclerotic plaques: a feasibility study 
  • Addressing the Conundrum of Bleeding and Cancer Detection With Antithrombotic Therapies for Chronic Atherosclerotic Cardiovascular Disease. 
  • Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. 
  • Adiposity and Incident Heart Failure and its Subtypes: MESA (Multi-Ethnic Study of Atherosclerosis). 
  • Admixture mapping scans identify a locus affecting retinal vascular caliber in hypertensive African Americans: the Atherosclerosis Risk in Communities (ARIC) study. 
  • Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. 
  • Affective brain patterns as multivariate neural correlates of cardiovascular disease risk. 
  • Age-related macular degeneration and cancer mortality in the atherosclerosis risk in communities study. 
  • Age-related macular degeneration and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. 
  • Age-related macular degeneration and progression of coronary artery calcium: The Multi-Ethnic Study of Atherosclerosis. 
  • Aging-related atherosclerosis is exacerbated by arterial expression of tumor necrosis factor receptor-1: evidence from mouse models and human association studies. 
  • Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA). 
  • An inflammatory pathway links atherosclerotic cardiovascular disease risk to neural activity evoked by the cognitive regulation of emotion. 
  • Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes. 
  • Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide. 
  • Angiotensin II synergizes with BAFF to promote atheroprotective regulatory B cells. 
  • Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. 
  • Anti-phosphorylcholine-opsonized low-density lipoprotein promotes rapid production of proinflammatory cytokines by dendritic cells and natural killer cells. 
  • Anticoagulation dosing in atherosclerotic cardiovascular disease: Is less more? 
  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. 
  • Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. 
  • Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. 
  • ApoB. 
  • Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. 
  • Apolipoprotein E gene polymorphisms are not associated with diabetic retinopathy: the atherosclerosis risk in communities study. 
  • Apolipoprotein E knock-out and knock-in mice: atherosclerosis, metabolic syndrome, and beyond. 
  • Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. 
  • Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease. 
  • Association Between Blood Pressure Classification Using the 2017 ACC/AHA Blood Pressure Guideline and Retinal Atherosclerosis. 
  • Association Between Long-Term Blood Pressure Variability and 10-Year Progression in Arterial Stiffness: The Multiethnic Study of Atherosclerosis. 
  • Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial. 
  • Association between frequency of primary care provider visits and evidence-based statin prescribing and statin adherence: Findings from the Veterans Affairs system. 
  • Association between physical activity and retinal microvascular signs: the Atherosclerosis Risk in Communities (ARIC) Study. 
  • Association between sleep disordered breathing and epigenetic age acceleration: Evidence from the Multi-Ethnic Study of Atherosclerosis. 
  • Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. 
  • Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies. 
  • Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. 
  • Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study. 
  • Association of the Novel Inflammatory Marker GlycA and Incident Heart Failure and Its Subtypes of Preserved and Reduced Ejection Fraction: The Multi-Ethnic Study of Atherosclerosis. 
  • Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease. 
  • Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Associations of candidate genes to age-related macular degeneration among racial/ethnic groups in the multi-ethnic study of atherosclerosis. 
  • Associations of cardiovascular risk factors, carotid intima-media thickness and left ventricular mass with inter-adventitial diameters of the common carotid artery: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Associations of cortisol/testosterone and cortisol/sex hormone-binding globulin ratios with atherosclerosis in middle-age women. 
  • Associations of edge-detected and manual-traced common carotid intima-media thickness measurements with Framingham risk factors: the multi-ethnic study of atherosclerosis. 
  • Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • AtheroSpectrum Reveals Novel Macrophage Foam Cell Gene Signatures Associated With Atherosclerotic Cardiovascular Disease Risk. 
  • Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol. 
  • Atherogenic lipoprotein parameters in patients with aggressive periodontitis. 
  • Atheromatous disease of the aorta and perioperative stroke. 
  • Atherosclerosis 2005: recent discoveries and novel hypotheses. 
  • Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. 
  • Atherosclerosis: Recent trials, new targets and future directions. 
  • Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. 
  • Atherosclerotic Peripheral Vascular Disease Symposium II: vascular magnetic resonance and computed tomographic imaging. 
  • Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes. 
  • Atherosclerotic renal artery stenosis in the post-CORAL era part 1: the renal penumbra concept and next-generation functional diagnostic imaging. 
  • Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in Transcatheter Nephron Salvage following flawed revascularization trials. 
  • Automated tracing of the adventitial contour of aortoiliac and peripheral arterial walls in CT angiography (CTA) to allow calculation of non-calcified plaque burden. 
  • Autophagy links inflammasomes to atherosclerotic progression. 
  • B cell depletion reduces the development of atherosclerosis in mice. 
  • Benchmarking association analyses of continuous exposures with RNA-seq in observational studies. 
  • Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients. 
  • Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. 
  • Biology of vascular calcification in renal disease. 
  • Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study. 
  • Birth weight is not related to risk of diabetic retinopathy in type 2 diabetes: the Atherosclerosis Risk in Communities Study. 
  • Blood monocyte transcriptome and epigenome analyses reveal loci associated with human atherosclerosis. 
  • Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS). 
  • CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. 
  • Cardiac transplantation at Duke University Medical Center. 
  • Cardiovascular Disease Prevention: Risk Assessment. 
  • Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study. 
  • Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). 
  • Cardiovascular risk factor profiles in familial hypercholesterolemia patients with and without genetic mutation compared to a nationally representative sample of adults in a high-risk European country. 
  • Cardiovascular screening in asymptomatic adults: lessons for the diving world. 
  • Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration. 
  • Catastrophic stroke burden in a patient with uncontrolled psoriasis and psoriatic arthritis: a case report. 
  • Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial. 
  • Cell therapy in murine atherosclerosis: in vivo imaging with high-resolution helical SPECT. 
  • Cerebellum as the normal reference for the detection of increased cerebral oxygen extraction. 
  • Cerebrovascular risk factors, vascular disease, and neuropsychological outcomes in adults with major depression. 
  • Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. 
  • Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. 
  • Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation. 
  • Classification of Atherosclerotic Rabbit Aorta Samples with an Infrared Attenuated Total Reflection Catheter and Multivariate Data Analysis 
  • Combination antithrombotic therapies. 
  • Combination lipid therapy: could teamwork make the dream work? 
  • Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. 
  • Common variants in the periostin gene influence development of atherosclerosis in young persons. 
  • Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease. 
  • Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. 
  • Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis. 
  • Concentration of Lp(a) (Lipoprotein[a]) in Aneurysm Sac Is Associated With Wall Enhancement of Unruptured Intracranial Aneurysm. 
  • Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry. 
  • Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 Diabetes: A Randomized Clinical Trial. 
  • Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. 
  • Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. 
  • DNA Methylation of the Aryl Hydrocarbon Receptor Repressor Associations With Cigarette Smoking and Subclinical Atherosclerosis. 
  • DNA-based animal models of human disease: from genotype to phenotype. 
  • Deficiency of MMP1a (Matrix Metalloprotease 1a) Collagenase Suppresses Development of Atherosclerosis in Mice: Translational Implications for Human Coronary Artery Disease. 
  • Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. 
  • Determining When to Add Nonstatin Therapy: A Quantitative Approach. 
  • Development and evaluation of a genetic risk score for obesity. 
  • Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease. 
  • Differentially conserved transcriptomic response to adversity related to self-rated health in the multi-ethnic study of atherosclerosis. 
  • Diuretic response in acute heart failure: clinical characteristics and prognostic significance. 
  • Does the clinical examination predict lower extremity peripheral arterial disease? 
  • Drebrin attenuates atherosclerosis by limiting smooth muscle cell transdifferentiation. 
  • Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry). 
  • Dual-energy computed tomography imaging of atherosclerotic plaques in a mouse model using a liposomal-iodine nanoparticle contrast agent. 
  • Duplication of the internal carotid artery presenting with severe atherosclerotic stenosis. 
  • Early atherosclerosis is associated with retinal microvascular changes in adolescents with type 1 diabetes. 
  • Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. 
  • Effect of hypercholesterolemia on transendothelial EBD-albumin permeability and lipid accumulation in porcine iliac arteries. 
  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. 
  • Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. 
  • Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease. 
  • Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS). 
  • Effects of simvastatin on retinal structure and function of a high-fat atherogenic mouse model of thickened Bruch's membrane. 
  • Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. 
  • Elevations in neutrophils with obstructive sleep apnea: The Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Emulating Early Atherosclerosis in a Vascular Microphysiological System Using Branched Tissue-Engineered Blood Vessels. 
  • Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. 
  • Endothelial dysfunction in chronic inflammatory diseases. 
  • Endothelial progenitor cell therapy for atherosclerosis: the philosopher's stone for an aging population? 
  • Endothelial progenitor cells: markers of vascular reparative capacity. 
  • Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis. 
  • Epigenetically mediated electrocardiographic manifestations of sub-chronic exposures to ambient particulate matter air pollution in the Women's Health Initiative and Atherosclerosis Risk in Communities Study. 
  • Epigenome-wide analysis of long-term air pollution exposure and DNA methylation in monocytes: results from the Multi-Ethnic Study of Atherosclerosis. 
  • Epigenome-wide association analysis of daytime sleepiness in the Multi-Ethnic Study of Atherosclerosis reveals African-American-specific associations. 
  • Eradicating Atherosclerosis: Should We Start Statins at Younger Ages and at Lower LDL-Cs. 
  • Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life. 
  • Estimation of Risk for Initial Atherosclerotic Cardiovascular Disease Events: Taking Stock and Moving Forward. 
  • Estimation of the transverse strain tensor in the arterial wall using ivus image registration 
  • Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis. 
  • Evaluating the association of social needs assessment data with cardiometabolic health status in a federally qualified community health center patient population. 
  • Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease. 
  • Evaluation of Factors Underlying Sex-Based Disparities in Cardiovascular Care in Adults With Self-reported Premature Atherosclerotic Cardiovascular Disease. 
  • Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical Research. 
  • Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study. 
  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. 
  • Evolving Role of Calcium Density in Coronary Artery Calcium Scoring and Atherosclerotic Cardiovascular Disease Risk. 
  • Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. 
  • Expression of socially sensitive genes: The multi-ethnic study of atherosclerosis. 
  • Expression of tumor necrosis factor receptor-1 in arterial wall cells promotes atherosclerosis. 
  • Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. 
  • Extracranial-intracranial bypass for ischemic cerebrovascular disease: what have we learned from the Carotid Occlusion Surgery Study? 
  • Falls, Subclinical Cardiovascular Disease, and a Nonagenarian's Sage Advice. 
  • Farnesoid-X Receptor (FXR) as a Promising Pharmaceutical Target in Atherosclerosis. 
  • Fibroblast growth factor-23 and cardiovascular events in CKD. 
  • Financial Hardship From Medical Bills Among Nonelderly U.S. Adults With Atherosclerotic Cardiovascular Disease. 
  • Fine mapping of a linkage peak with integration of lipid traits identifies novel coronary artery disease genes on chromosome 5. 
  • Flow-Dependent Epigenetic DNA Methylation in Endothelial Gene Expression and Atherosclerosis. 
  • Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis 
  • From the editor: A run of success in treating atherosclerotic vascular disease. 
  • From the editor: Atherosclerosis in different flavors. 
  • From the editor: Homeward bound? 
  • From the editor: Lessons from the East. 
  • From the editor: O Canada! A tariff-free zone for scientific exchange. 
  • Frontiers in cardiovascular magnetic resonance. 
  • G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors. 
  • GLP-1 receptor activation indirectly reduces hepatic lipid accumulation but does not attenuate development of atherosclerosis in diabetic male ApoE(-/-) mice. 
  • Gender differences in the relationships among obesity, adiponectin and brachial artery distensibility in adolescents and young adults. 
  • Gene by stress genome-wide interaction analysis and path analysis identify EBF1 as a cardiovascular and metabolic risk gene. 
  • Gene expression associations with body mass index in the Multi-Ethnic Study of Atherosclerosis. 
  • Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals. 
  • Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease. 
  • Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis. 
  • Genetic variation associated with circulating monocyte count in the eMERGE Network. 
  • Genome-wide association of pericardial fat identifies a unique locus for ectopic fat. 
  • Genome-wide association study on progression of carotid artery intima media thickness over 10 years in a Chinese cohort. 
  • Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. 
  • Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. 
  • Genomic modeling of atherosclerosis in peripheral arterial disease and its variant phenotype in patients with diabetes. 
  • Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study. 
  • Glutathione peroxidase-deficient smooth muscle cells cause paracrine activation of normal smooth muscle cells via cyclophilin A. 
  • Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. 
  • Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis. 
  • Guidelines for the performance of a comprehensive intraoperative epiaortic ultrasonographic examination: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists; endorsed by the Society of Thoracic Surgeons. 
  • HbA 1c as a risk factor for heart failure in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) study. 
  • Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. 
  • Hepatocyte Growth Factor and Incident Heart Failure Subtypes: The Multi-Ethnic Study of Atherosclerosis (MESA). 
  • High platelet reactivity to multiple agonists during aspirin and clopidogrel treatment is indicative of a global hyperreactive platelet phenotype. 
  • High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes. 
  • High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S. 
  • Highlights in ASCVD Primary Prevention for 2021. 
  • How asymptomatic is asymptomatic carotid stenosis? 
  • Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. 
  • Hypertension among adults enrolled in HIV care in northern Tanzania: comorbidities, cardiovascular risk, and knowledge, attitudes and practices. 
  • Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases. 
  • Impact of Aortic Atherosclerosis Burden on Outcomes of Surgical Aortic Valve Replacement. 
  • Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry. 
  • Improving patient risk communication: Translating cardiovascular risk into standardized risk percentiles. 
  • In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 y. 
  • In Situ Venous Bypass for Chronic Hand Ischemia: A Review of 25 Cases in 23 Patients. 
  • In vivo differences between endothelial transcriptional profiles of coronary and iliac arteries revealed by microarray analysis 
  • Incidence of Age-Related Macular Degeneration in a Multi-Ethnic United States Population: The Multi-Ethnic Study of Atherosclerosis. 
  • Incidence of postoperative stroke using the Heartstring device in 1,380 coronary artery bypass graft patients with mild to severe atherosclerosis of the ascending aorta. 
  • Increased Concentrations of Atherogenic Proteins in Aneurysm Sac Are Associated with Wall Enhancement of Unruptured Intracranial Aneurysm. 
  • Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis. 
  • Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. 
  • Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. 
  • Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration. 
  • Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. 
  • Infrainguinal arterial intervention: is there a role for an atherectomy device? 
  • Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial. 
  • Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. 
  • International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. 
  • Is early age-related macular degeneration related to carotid artery stiffness? The Atherosclerosis Risk in Communities Study. 
  • Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The multi-ethnic study of atherosclerosis (MESA). 
  • Ischemia With Nonobstructive Coronary Arteries: Insights From the ISCHEMIA Trial. 
  • JCL Roundtable: Global Think Tank on Lipoprotein(a). 
  • JCL roundtable-Lipoprotein(a): The emerging risk factor. 
  • JCL roundtable: Healthy ethnic diets. 
  • JCL roundtable: High-density lipoprotein function and reverse cholesterol transport. 
  • JCL roundtable: Lipid treatment targets. 
  • JCL roundtable: Lipids and inflammation in atherosclerosis. 
  • JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes. 
  • JCL roundtable: South Asian atherosclerotic risk. 
  • KCNJ11 variants and their effect on the association between serum potassium and diabetes risk in the Atherosclerosis Risk in Communities (ARIC) Study and Jackson Heart Study (JHS) cohorts. 
  • Kruppel-like factor 15 is critical for vascular inflammation. 
  • Leukocyte Traits and Exposure to Ambient Particulate Matter Air Pollution in the Women's Health Initiative and Atherosclerosis Risk in Communities Study. 
  • Life course socioeconomic status and DNA methylation in genes related to stress reactivity and inflammation: The multi-ethnic study of atherosclerosis. 
  • Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. 
  • Lipid-lowering treatment among older patients with atherosclerotic cardiovascular disease. 
  • Lipoprotein(a) Testing Patterns in a Large Health System. 
  • LncRNA VINAS regulates atherosclerosis by modulating NF-κB and MAPK signaling. 
  • Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome. 
  • Long Noncoding RNAs in Atherosclerosis and Vascular Injury: Pathobiology, Biomarkers, and Targets for Therapy. 
  • Long-term cardiovascular outcomes in patients with atrial fibrillation and atherothrombosis in the REACH Registry. 
  • Long-term outdoor air pollution and DNA methylation in circulating monocytes: results from the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry. 
  • Low human and murine Mcl-1 expression leads to a pro-apoptotic plaque phenotype enriched in giant-cells. 
  • Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS. 
  • Lymphocyte activation gene-3-associated protein networks are associated with HDL-cholesterol and mortality in the Trans-omics for Precision Medicine program. 
  • Macrophage deficiency of p38alpha MAPK promotes apoptosis and plaque necrosis in advanced atherosclerotic lesions in mice. 
  • Management of Patients with Asymptomatic and Symptomatic Carotid Artery Disease: Update on Anti-Thrombotic Therapy. 
  • Management of coronary artery disease in end-stage renal disease. 
  • Managing Atherosclerotic Cardiovascular Risk in Young Adults: JACC State-of-the-Art Review. 
  • Markers of Atherosclerosis, Clinical Characteristics, and Treatment Patterns in Heart Failure: A Case-Control Study of Middle-Aged Adult Heart Failure Patients in Rural Kenya. 
  • Metabolic syndrome, diabetes mellitus, or both and cardiovascular risk in outpatients with or at risk for atherothrombosis. 
  • Metabolomic profile associated with insulin resistance and conversion to diabetes in the Insulin Resistance Atherosclerosis Study. 
  • Methylomics of gene expression in human monocytes. 
  • Midterm outcomes in patients undergoing endovascular repair of thoracic aortic aneurysms and penetrating atherosclerotic ulcers using the RelayPlus stent graft. 
  • Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. 
  • Modeling early stage atherosclerosis in a primary human vascular microphysiological system. 
  • Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets. 
  • Modulating atherothrombosis: is there a place for vaccines in global prevention strategies? 
  • Molecular evidence for arterial repair in atherosclerosis. 
  • Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis. 
  • Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis. 
  • NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease. 
  • Natural history of penetrating atherosclerotic ulcers in aortic branch vessels. 
  • Neighborhood characteristics influence DNA methylation of genes involved in stress response and inflammation: The Multi-Ethnic Study of Atherosclerosis. 
  • Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis. 
  • Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. 
  • New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis. 
  • Nighttime blood pressure dipping in young adults and coronary artery calcium 10-15 years later: the coronary artery risk development in young adults study. 
  • No association of 9p21 with arterial elasticity and retinal microvascular findings. 
  • Non-traditional risk factors are important contributors to the racial disparity in diabetes risk: the atherosclerosis risk in communities study. 
  • Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis. 
  • Noninvasive assessment of wall-shear rate and vascular elasticity using combined ARFI/SWEI/spectral Doppler imaging system. 
  • Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! 
  • Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production. 
  • One-year cardiovascular event rates in outpatients with atherothrombosis. 
  • Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease. 
  • Parathyroid Hormone and the Use of Diuretics and Calcium-Channel Blockers: The Multi-Ethnic Study of Atherosclerosis. 
  • Patterns of infarction in hemodynamic failure. 
  • Performance of the Pooled Cohort Equations in non-alcoholic fatty liver disease: The Multi-Ethnic Study of Atherosclerosis. 
  • Pericardial fat volume and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis and Jackson Heart Study. 
  • Physical Activity and Incident Heart Failure in High-Risk Subgroups: The ARIC Study. 
  • Physical activity, television viewing time, and retinal microvascular caliber: the multi-ethnic study of atherosclerosis. 
  • Plasma sphingomyelin is not associated with microvascular changes in the retina. 
  • Platelets from genome to proteome and beyond. 
  • Platelets in atherothrombosis. 
  • Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality. 
  • Polymorphic variants in tenascin-C (TNC) are associated with atherosclerosis and coronary artery disease. 
  • Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease. 
  • Polyvascular Disease: Reappraisal of the Current Clinical Landscape. 
  • Polyvascular disease: A narrative review of current evidence and a consideration of the role of antithrombotic therapy. 
  • Potassium Measures and Their Associations with Glucose and Diabetes Risk: The Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Preclinical atherosclerosis covaries with individual differences in reactivity and functional connectivity of the amygdala. 
  • Prediabetes and the association with unrecognized myocardial infarction in the multi-ethnic study of atherosclerosis. 
  • Prediction of incident heart failure in general practice: the Atherosclerosis Risk in Communities (ARIC) Study. 
  • Predictive Accuracy of Stroke Risk Prediction Models Across Black and White Race, Sex, and Age Groups. 
  • Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? 
  • Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. 
  • Prevalence and Prognostic Significance of Polyvascular Disease in Patients Hospitalized With Acute Decompensated Heart Failure: The ARIC Study. 
  • Prevalence and characteristics of choroidal nevi: the multi-ethnic study of atherosclerosis. 
  • Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. 
  • Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. 
  • Prevention of cardiovascular disease: time for a course correction. 
  • Pro- and antiatherogenic effects of a dominant-negative P465L mutation of peroxisome proliferator-activated receptor-γ in apolipoprotein E-Null mice. 
  • Protein prediction for trait mapping in diverse populations. 
  • Proteomic Architecture of Human Coronary and Aortic Atherosclerosis. 
  • Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy. 
  • Psychosocial risk factors and retinal microvascular signs: the multi-ethnic study of atherosclerosis. 
  • Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry. 
  • Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. 
  • Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. 
  • Racial differences of lipoprotein subclass distributions in postmenopausal women. 
  • Racial variations in the prevalence of refractive errors in the United States: the multi-ethnic study of atherosclerosis. 
  • Radiation exposure and coronary atherothrombosis. 
  • Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD). 
  • Recreational substance use among patients with premature atherosclerotic cardiovascular disease. 
  • Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. 
  • Regression of atherosclerosis with therapeutic antibodies pipe cleaner or pipe dream? 
  • Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score. 
  • Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy. 
  • Relationship between retinal arteriolar narrowing and myocardial perfusion: multi-ethnic study of atherosclerosis. 
  • Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Renal function, atherothrombosis extent, and outcomes in high-risk patients. 
  • Reply: Heart Failure With Preserved Ejection Fraction: Types 1 and 2? 
  • Reply: To PMID 22954239. 
  • Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. 
  • Rethinking stable ischemic heart disease: is this the beginning of a new era? 
  • Retinal arterial signs and coronary heart disease. 
  • Retinal arteriolar caliber and urine albumin excretion: the Multi-Ethnic Study of Atherosclerosis. 
  • Retinal arteriolar narrowing and left ventricular hypertrophy in African Americans. the Atherosclerosis Risk in Communities (ARIC) study. 
  • Retinal arteriolar narrowing and left ventricular remodeling: the multi-ethnic study of atherosclerosis. 
  • Retinal arteriolar narrowing and subsequent development of CKD Stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Retinal microvascular abnormalities and MRI-defined subclinical cerebral infarction: the Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. 
  • Retinal microvascular calibre and risk of incident diabetes: the multi-ethnic study of atherosclerosis. 
  • Retinal microvascular signs and 10-year risk of cerebral atrophy: the Atherosclerosis Risk in Communities (ARIC) study. 
  • Retinal microvascular signs and risk of stroke: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Retinal microvascular structure and function in patients with risk factors of atherosclerosis and coronary artery disease. 
  • Retinal vascular caliber and brachial flow-mediated dilation: the Multi-Ethnic Study of Atherosclerosis. 
  • Retinal vessel diameters and risk of hypertension: the Multiethnic Study of Atherosclerosis. 
  • Review article: the impact of liver-directed therapies on the atherogenic risk profile in non-alcoholic steatohepatitis. 
  • Revisiting flow augmentation bypass for cerebrovascular atherosclerotic vaso-occlusive disease: Single-surgeon series and review of the literature. 
  • Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. 
  • Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rate. 
  • Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. 
  • Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. 
  • Role for Nox1 NADPH oxidase in atherosclerosis. 
  • Role of DNA methylation on the association between physical activity and cardiovascular diseases: results from the longitudinal multi-ethnic study of atherosclerosis (MESA) cohort. 
  • Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. 
  • Roundtable discussion: Dietary fats in prevention of atherosclerotic cardiovascular disease. 
  • Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. 
  • Semiautomated quantification of the mass and distribution of vascular calcification with multidetector CT: method and evaluation. 
  • Serum Phosphate and Retinal Microvascular Changes: The Multi-Ethnic Study of Atherosclerosis and the Beaver Dam Eye Study. 
  • Serum alpha-1 antitrypsin in acute ischemic stroke: A prospective pilot study. 
  • Serum and dietary potassium and risk of incident type 2 diabetes mellitus: The Atherosclerosis Risk in Communities (ARIC) study. 
  • Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study. 
  • Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States. 
  • Sibling history of myocardial infarction or stroke and risk of cardiovascular disease in the elderly: the Cardiovascular Health Study. 
  • Sleep apnea and retinal signs in cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. 
  • Social factors and leukocyte DNA methylation of repetitive sequences: the multi-ethnic study of atherosclerosis. 
  • Social regulation of inflammation related gene expression in the multi-ethnic study of atherosclerosis. 
  • Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study. 
  • Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events. 
  • Statin intolerance: more questions than answers. 
  • Statin pretreatment is associated with better outcomes in large artery atherosclerotic stroke. 
  • Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease. 
  • Statins for stroke prevention. 
  • Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial. 
  • Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease. 
  • Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study. 
  • Subclinical Vascular Disease Burden and Premature Mortality Among Middle-aged Adults: the Atherosclerosis Risk in Communities Study. 
  • Targeting phosphorylation of eukaryotic initiation factor-2α to treat human disease. 
  • Temporal Trends and Prognosis of Physical Examination Findings in Patients With Acute Decompensated Heart Failure: The ARIC Study Community Surveillance. 
  • Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study). 
  • Ten-year longitudinal changes in retinal microvascular lesions: the atherosclerosis risk in communities study. 
  • The "sandblasting" effect of aortic cannula on arch atheroma during cardiopulmonary bypass. 
  • The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia. 
  • The Association of Sport and Exercise Activities With Cardiovascular Disease Risk: The Atherosclerosis Risk in Communities (ARIC) Study. 
  • The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia. 
  • The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid Lowering. 
  • The Hybrid Mouse Diversity Panel: a resource for systems genetics analyses of metabolic and cardiovascular traits. 
  • The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study. 
  • The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease. 
  • The Socioeconomic Gradient in Epigenetic Ageing Clocks: Evidence from the Multi-Ethnic Study of Atherosclerosis and the Health and Retirement Study. 
  • The association between aging-related monocyte transcriptional networks and comorbidity burden: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II. 
  • The challenges of data safety monitoring for a pragmatic study: Lessons from the ADAPTABLE study. 
  • The economics of PCSK-9 inhibitors. 
  • The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). 
  • The role of epigenetics in the endothelial cell shear stress response and atherosclerosis 
  • The role of hyaluronic acid in atherosclerosis and intimal hyperplasia. 
  • The role of type 1 angiotensin receptors on T lymphocytes in cardiovascular and renal diseases. 
  • Therapy and clinical trials. 
  • Thiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPar gamma agonism. 
  • Thrombin receptor antagonists for the treatment of atherothrombosis: therapeutic potential of vorapaxar and E-5555. 
  • Thrombotic preparedness in aging: a translatable construct for thrombophilias? 
  • Thyroid Dysfunction and Atherosclerosis: A Systematic Review. 
  • Time-dependent event accumulation in a cardiovascular outcome trial of patients with type 2 diabetes and established atherosclerotic cardiovascular disease. 
  • Tobacco exposure-related alterations in DNA methylation and gene expression in human monocytes: the Multi-Ethnic Study of Atherosclerosis (MESA). 
  • Toll-like receptors, their ligands, and atherosclerosis. 
  • Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. 
  • Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. 
  • Tribute to Dr. Steve Schwartz. 
  • Type 2 Diabetes and Atherosclerotic Cardiovascular Disease in South Asians: a Unique Population with a Growing Challenge. 
  • USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis. 
  • Up-regulating sphingosine 1-phosphate receptor-2 signaling impairs chemotactic, wound-healing, and morphogenetic responses in senescent endothelial cells. 
  • Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort. 
  • Use of Lipid-, Blood Pressure-, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease. 
  • Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. 
  • Use of atorvastatin in systemic lupus erythematosus in children and adolescents. 
  • Usefulness of Coronary Artery Calcium to Predict Heart Failure With Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis). 
  • Usefulness of carotid intima-media thickness measurement as an indicator of generalized atherosclerosis: findings from autopsy analysis. 
  • Utility of FDG PET/CT in inflammatory cardiovascular disease. 
  • Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk. 
  • Vascular dementia: atherosclerosis, cognition and Alzheimer's disease. 
  • Vascular smooth muscle cells in cerebral aneurysm pathogenesis. 
  • Visual Impairment in White, Chinese, Black, and Hispanic Participants from the Multi-Ethnic Study of Atherosclerosis Cohort. 
  • Vulnerable plaque intervention: State of the art. 
  • Warfarin-induced vasculopathy. 
  • Western-type diet modulates inflammatory responses and impairs functional outcome following permanent middle cerebral artery occlusion in aged mice expressing the human apolipoprotein E4 allele. 
  • [First guidelines on fat consumption and cardiovascular health]. 
  • [Recent advances in atherothrombotic diseases]. 
• 

  Keywords of People

  • Granger, Christopher Bull, Professor of Medicine, School of Nursing
  • Liu, Yongmei, Professor of Medicine, Medicine, Cardiology
  • Miller Jr., Francis Joseph, Adjunct Professor in the Department of Medicine, Medicine, Cardiology
  • Randles, Amanda, Alfred Winborne and Victoria Stover Mordecai Assistant Professor of Biomedical Sciences, Thomas Lord Department of Mechanical Engineering and Materials Science
  • Schanberg, Laura Eve, Professor of Pediatrics, Pediatrics, Rheumatology